Alector to Participate in the Bank of America CNS Therapeutics Conference

Rhea-AI Summary

Alector (Nasdaq: ALEC) announced that management will participate in a fireside chat at the Bank of America CNS Therapeutics Conference on Monday, December 8, 2025 at 2:25 pm ET. A live webcast will be available on the company’s Investors > Events & Presentations page at http://investors.alector.com. A replay will be posted on the Alector website and will remain available for 90 days following the event.

SOUTH SAN FRANCISCO, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a fireside chat at the Bank of America CNS Therapeutics Conference, being held virtually on Monday, December 8, 2025, at 2:25 pm ET.

A webcast of the fireside chat will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. A replay will be available on the Alector website for 90 days following the event.

About Alector
Alector is a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. Leveraging the principles of genetics, immunology, and neuroscience, the company is advancing a portfolio of programs that aim to remove toxic proteins, replace missing proteins, and restore immune and nerve cell function. Supported by biomarkers, Alector’s product candidates seek to treat a range of indications, such as Alzheimer’s disease, Parkinson's disease, and frontotemporal dementia. The company is also developing Alector Brain Carrier (ABC), a proprietary blood-brain barrier platform, which is being selectively applied to its preclinical and research pipeline. ABC aims to enhance the delivery of therapeutics, achieve deeper brain penetration and efficacy at lower doses, and ultimately improve patient outcomes while reducing costs. Alector is headquartered in South San Francisco, California. For more information, please visit www.alector.com.

Alector Contacts:

Argot Partners (media)
David Rosen
(212) 600-1494
alector@argotpartners.com

Argot Partners (investors)
Laura Perry
(212) 600-1902
alector@argotpartners.com

FAQ

When will Alector (ALEC) present at the Bank of America CNS Therapeutics Conference?

Alector management is scheduled for a fireside chat on December 8, 2025 at 2:25 pm ET.

How can investors watch the Alector (ALEC) webcast for the December 8, 2025 fireside chat?

Watch the live webcast on the company’s Investors > Events & Presentations page at http://investors.alector.com.

Will a replay of Alector's (ALEC) Bank of America presentation be available?

Yes, a replay will be posted on Alector’s website and will be available for 90 days after the event.

Is the Bank of America CNS Therapeutics Conference Alector (ALEC) presentation virtual or in person?

The event is being held virtually, and Alector’s presentation will be accessible via webcast.

Where on the Alector site is the webcast link for the December 8, 2025 presentation?

The webcast link will be posted on the Events & Presentations page within the Investors section at http://investors.alector.com.